What type of group does Breakthrough Prize in Life Sciences and Anne Wojcicki have in common?
company
Anne Wojcicki
Anne E. Wojcicki ( ; ] ; born July 28, 1973) is an American entrepreneur and the co-founder and chief executive officer of the personal genomics company 23andMe.
 She was formerly married to Google co-Founder Sergey Brin.
Breakthrough Prize in Life Sciences
The Breakthrough Prize in Life Sciences is a monetary award, funded by internet entrepreneurs: Mark Zuckerberg and Priscilla Chan of Facebook; Sergey Brin of Google; entrepreneur and venture capitalist Yuri Milner; and Anne Wojcicki, one of the founders of the genetics company 23andMe.
 The Chairman of the Board is Arthur D. Levinson of Apple.
Yoshinori Ohsumi
Yoshinori Ohsumi (大隅 良典 , Ōsumi Yoshinori , born February 9, 1945) is a Japanese cell biologist specializing in autophagy, the process that cells use to destroy and recycle cellular components.
 Ohsumi is a professor at Tokyo Institute of Technology's Institute of Innovative Research.
 He received the Kyoto Prize for Basic Sciences in 2012, the 2016 Nobel Prize in Physiology or Medicine, and the 2017 Breakthrough Prize in Life Sciences for his discoveries of mechanisms for autophagy. Albany Medical Center Prize
The Albany Medical Center Prize in Medicine and Biomedical Research is the United States' second highest value prize in medicine and biomedical research, awarded by the Albany Medical Center.
 Among prizes for medicine worldwide, the Albany Medical Center Prize is the fourth most lucrative (after the $3 million Breakthrough Prize in Life Sciences, the $1.2 million Nobel Prize in Medicine and the $1 million Shaw Prize in life science and medicine). Life Sciences Research Foundation
The Life Sciences Research Foundation (LSRF) is a postdoctoral fellowship program, with missions ""to identify and fund exceptional young scientists at a critical juncture of their training in all areas of basic life sciences"" and ""to establish partnerships between those who support research in the life sciences and academic institutions for their mutual benefit"".
 LSRF was established in 1983 by Donald D. Brown of the Carnegie Institution for Science, Department of Embryology.
 As one of four highly competitive postdoctoral awards in the life sciences, each year LSRF receives more than 1000 applications and awards 15-25 fellowships.
 The Board of Directors also includes Douglas Koshland and Solomon H. Snyder.
 The 56 sponsors include many top companies in the biotech and pharmaceutical industry.
 In 2012, Brown won the Albert Lasker Special Achievement Award in Medical Science, in part for his initiation and 30-year dedication to LSRF. Helen Hobbs
Helen Hobbs is a professor at the University of Texas Southwestern Medical Center, and a Howard Hughes Medical Institute investigator, who won a 2016 Breakthrough Prize in Life Sciences and the 2015 Pearl Meister Greengard Prize.
 She helped find that people with hypomorphic PCSK9 mutations had lower LDL levels, and were almost immune to heart disease.
 This discovery helped lead to cholesterol-lowering drugs that mimicked the effects of the PCSK9 mutations.
 She sits on the board of directors at Pfizer. Hans Clevers
Johannes Carolus (Hans) Clevers (born 27 March 1957) is a professor in molecular genetics, a geneticist, physician, medical researcher who was the first to identify stem cells in the intestine and is one of the world's leading researchers on normal stem cells and their potential for regenerative therapy.
 Clevers obtained his M.D. in 1984 and his Ph.D. in 1985 at Utrecht University and was a professor in immunology there between 1991 and 2002.
 Since then, he is Professor in Molecular Genetics at the UMC Utrecht and University Utrecht.
 He received the Spinoza Prize in 2001 and became director of the Hubrecht Institute in 2002.
 He was elected as the president of the Royal Netherlands Academy of Arts and Sciences (KNAW) to succeed Robbert Dijkgraaf from 2012-2015.
 Clevers has his own research group at the Hubrecht Institute and is director Research of the Princess Maxima Center for pediatric oncology since 1 June 2015.
 In 2013 he was awarded the $3 million Breakthrough Prize in Life Sciences for his work .
 In 2014 he became one of the national icons of the Netherlands. Cornelia Bargmann
Cornelia Isabella "Cori" Bargmann (born 1961) is an American neurobiologist.
 She is known for her work on the behavior in the C. elegans, particularly olfaction in the worm.
 Studying the C. elegans is allowing Bargmann to uncover how neurons and genes affect behavior.
 Knowing that many of the gene mechanisms in roundworms mimic those of mammals, she is able to manipulate certain genes and observe how that affects changes in behavior.
 She has been elected to the National Academy of Sciences and had been a Howard Hughes Medical Institute investigator at UCSF and then Rockefeller University from 1995 to 2016.
 It was announced on September 21, 2016 that she had been named the incoming president of science at the Chan Zuckerberg Initiative, effective October 1, 2016.
 In 2012 she was awarded the $1 million Kavli Prize, and in 2013 the $3 million Breakthrough Prize in Life Sciences. Life Sciences Greenhouse of Central Pennsylvania
Life Sciences Greenhouse of Central Pennsylvania (LSGPA) is a biotechnology initiative and non-profit organization based in Harrisburg, Pennsylvania specializing in the advancement of life sciences through technology to improve the healthcare and enhanced economic opportunity of Pennsylvanians.
 The initiative began in 2001, funded with money from the state's settlement with the tobacco industry.
 Other life sciences greenhouses in Philadelphia and Pittsburgh also received seed money from the settlement.
 The LSGPA partners with a range of institutions, including local research universities, colleges, medical centers, economic development agencies and companies both small and large, to identify needs and opportunities.
 The organization then works to help transfer technologies, to develop new companies, to provide support for existing companies (particularly those seeking to expand or relocate), and to ensure that the infrastructure necessary to support a thriving life sciences industry keeps pace with development. Richard P. Lifton
Richard P. Lifton (born 1953) is an American biochemist, and the president of The Rockefeller University.
 He earned his B.A. in biological sciences from Dartmouth College and in 1986 he got his M.D. and Ph.D. in biochemistry from Stanford University.
 He trained at Brigham and Women's Hospital before starting his lab at Yale in 1993.
 He has been awarded the Wiley Prize in Biomedical Sciences for his discovery of genes that are associated with the regulation of blood pressure.
 In 2014 he was awarded the $3 million Breakthrough Prize in Life Sciences for his work.
 He has been a Howard Hughes Medical Institute (HHMI) investigator since 1994.
 He was inducted into the National Academy of Science, Institute of Medicine, and is a Fellow of the American Association for the Advancement of Science.